Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Trial of Leuco methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease (2014-2017)

Professor Gerard Byrne

Mayne Professor of Psychiatry

Medical School

Faculty of Health, Medicine and Behavioural Sciences